During the the National Comprehensive Cancer Network 15th Annual Conference, updates were presented for various NCCN Clinical Practice Guidelines.
The National Comprehensive Cancer Network (NCCN) 15th Annual Conference took place from Wednesday, March 10, to Sunday, March 14, at The Westin Diplomat in Hollywood, Florida. During the meeting, updates were presented for various NCCN Clinical Practice Guidelines, including colon cancer, breast cancer, cervical cancer, occult primary, acute myeloid leukemia, multiple myeloma, non-small cell lung cancer, esophageal cancer, and prostate cancer. New NCCN Guidelines were also presented for mesothelioma. All of the NCCN Clinical Practice Guidelines are available at www.nccn.org/professionals/physician_gls/f_guidelines.asp.
The NCCN Conference also featured two dynamic roundtable discussions, one focusing on end of life issues, which was moderated by Sam Donaldson, and one examining clinical and economic issues impacting cancer care delivery, which was moderated by Clifford Goodman, PhD. Between guideline updates, there were educational sessions, including on human papillomavirus and cancer risk, pharmacy in oncology, cancer in adolescents and young patients, new advances in molecular diagnostics, and management of treatment-related infections, thromboses, and neuropathy. To obtain a CD ROM from this meeting or other NCCN conferences, such as the NCCN 4th Annual Congress on Hematological Malignancies, visit http://bit.ly/cqIM4C.
Interested in attending a NCCN meeting? The NCCN 5th Annual Congress on Hematological Malignancies will be taking place in New York City from October 8 to 9 at the New York Marriott Marquis. This Congress will “review multiple myeloma, chronic myelogenous leukemia, chronic lymphocytic leukemia, myelodysplasia and acute myeloid leukemia with respect to treatment at initial presentation, relapse, and when to consider bone marrow transplantation.”
For more information, visit www.nccn.org/professionals/meetings/hematological/default.asp, or to order enduring material from the NCCN 4th Annual Congress on Hematological Malignancies, visit http://nccn.cmeport.com/moduleDetail.aspx?id=55.